The emerging therapy of the medication represents a major breakthrough in the management of diabetes mellitus type 2. Different to existing medications, tirzepatide affects multiple pathways – GLP-1 and the GIP https://tirzepatide-peptide930044.ssnblog.com/40585013/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment